ferric nitrilotriacetate has been researched along with Liver Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, MK; Athar, M; Iqbal, M | 1 |
| Khan, S; O'Brien, PJ; Zhao, ZS | 1 |
| Maeda, R; Ogura, M; Toki, J | 1 |
3 other study(ies) available for ferric nitrilotriacetate and Liver Dysfunction
| Article | Year |
|---|---|
Vitamin E inhibits hepatic oxidative stress, toxicity and hyperproliferation in rats treated with the renal carcinogen ferric nitrilotriacetate.
Topics: Animals; Antioxidants; Carcinogens; Cell Proliferation; Dose-Response Relationship, Drug; Ferric Compounds; Kidney; Lipid Peroxidation; Liver; Liver Diseases; Male; Nitrilotriacetic Acid; Oxidative Stress; Rats; Rats, Wistar; Vitamin E | 2005 |
The prevention of ferric nitrilotriacetate-induced nephro- and hepatotoxicity by methylenedioxybenzene antioxidants.
Topics: Animals; Antioxidants; Carcinogens; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Dioxoles; Ferric Compounds; Kidney; Kidney Diseases; Lipid Peroxidation; Liver; Liver Diseases; Male; Mice; Microsomes, Liver; Necrosis; Nitrilotriacetic Acid; Rats; Rats, Sprague-Dawley; Safrole | 1997 |
An electron microscopical and histochemical study on ferric nitrilotriacetate-induced "F1 amyloidosis".
Topics: Amyloidosis; Animals; Crosses, Genetic; Disease Models, Animal; Female; Ferric Compounds; Histocytochemistry; Injections, Intraperitoneal; Iron; Kidney Diseases; Liver Diseases; Male; Mice; Mice, Inbred ICR; Microscopy, Electron; Nitrilotriacetic Acid; Pedigree; Splenic Diseases | 1986 |